These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34582479)

  • 1. Knocking out TMEM38B in human foetal osteoblasts hFOB 1.19 by CRISPR/Cas9: A model for recessive OI type XIV.
    Leoni L; Tonelli F; Besio R; Gioia R; Moccia F; Rossi A; Forlino A
    PLoS One; 2021; 16(9):e0257254. PubMed ID: 34582479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of TRIC-B from type XIV Osteogenesis Imperfecta osteoblasts alters cell adhesion and mitochondrial function - A multi-omics study.
    Jovanovic M; Mitra A; Besio R; Contento BM; Wong KW; Derkyi A; To M; Forlino A; Dale RK; Marini JC
    Matrix Biol; 2023 Aug; 121():127-148. PubMed ID: 37348683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of the ER Cation Channel TMEM38B/TRIC-B Disrupts Intracellular Calcium Homeostasis and Dysregulates Collagen Synthesis in Recessive Osteogenesis Imperfecta.
    Cabral WA; Ishikawa M; Garten M; Makareeva EN; Sargent BM; Weis M; Barnes AM; Webb EA; Shaw NJ; Ala-Kokko L; Lacbawan FL; Högler W; Leikin S; Blank PS; Zimmerberg J; Eyre DR; Yamada Y; Marini JC
    PLoS Genet; 2016 Jul; 12(7):e1006156. PubMed ID: 27441836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zebrafish Tric-b is required for skeletal development and bone cells differentiation.
    Tonelli F; Leoni L; Daponte V; Gioia R; Cotti S; Fiedler IAK; Larianova D; Willaert A; Coucke PJ; Villani S; Busse B; Besio R; Rossi A; Witten PE; Forlino A
    Front Endocrinol (Lausanne); 2023; 14():1002914. PubMed ID: 36755921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CaMKII inhibition due to TRIC-B loss-of-function dysregulates SMAD signaling in osteogenesis imperfecta.
    Besio R; Contento BM; Garibaldi N; Filibian M; Sonntag S; Shmerling D; Tonelli F; Biggiogera M; Brini M; Salmaso A; Jovanovic M; Marini JC; Rossi A; Forlino A
    Matrix Biol; 2023 Jun; 120():43-59. PubMed ID: 37178987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic Spectrum in Osteogenesis Imperfecta Due to Mutations in TMEM38B: Unraveling a Complex Cellular Defect.
    Webb EA; Balasubramanian M; Fratzl-Zelman N; Cabral WA; Titheradge H; Alsaedi A; Saraff V; Vogt J; Cole T; Stewart S; Crabtree NJ; Sargent BM; Gamsjaeger S; Paschalis EP; Roschger P; Klaushofer K; Shaw NJ; Marini JC; Högler W
    J Clin Endocrinol Metab; 2017 Jun; 102(6):2019-2028. PubMed ID: 28323974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel deletion mutation involving TMEM38B in a patient with autosomal recessive osteogenesis imperfecta.
    Rubinato E; Morgan A; D'Eustacchio A; Pecile V; Gortani G; Gasparini P; Faletra F
    Gene; 2014 Jul; 545(2):290-2. PubMed ID: 24835313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two novel mutations in TMEM38B result in rare autosomal recessive osteogenesis imperfecta.
    Lv F; Xu XJ; Wang JY; Liu Y; Asan ; Wang JW; Song LJ; Song YW; Jiang Y; Wang O; Xia WB; Xing XP; Li M
    J Hum Genet; 2016 Jun; 61(6):539-45. PubMed ID: 26911354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIC-B Mutations Causing Osteogenesis Imperfecta.
    Ichimura A; Takeshima H
    Biol Pharm Bull; 2016; 39(11):1743-1747. PubMed ID: 27803445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mice lacking the intracellular cation channel TRIC-B have compromised collagen production and impaired bone mineralization.
    Zhao C; Ichimura A; Qian N; Iida T; Yamazaki D; Noma N; Asagiri M; Yamamoto K; Komazaki S; Sato C; Aoyama F; Sawaguchi A; Kakizawa S; Nishi M; Takeshima H
    Sci Signal; 2016 May; 9(428):ra49. PubMed ID: 27188440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crtap and p3h1 knock out zebrafish support defective collagen chaperoning as the cause of their osteogenesis imperfecta phenotype.
    Tonelli F; Cotti S; Leoni L; Besio R; Gioia R; Marchese L; Giorgetti S; Villani S; Gistelinck C; Wagener R; Kobbe B; Fiedler IAK; Larionova D; Busse B; Eyre D; Rossi A; Witten PE; Forlino A
    Matrix Biol; 2020 Aug; 90():40-60. PubMed ID: 32173581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A deletion mutation in TMEM38B associated with autosomal recessive osteogenesis imperfecta.
    Volodarsky M; Markus B; Cohen I; Staretz-Chacham O; Flusser H; Landau D; Shelef I; Langer Y; Birk OS
    Hum Mutat; 2013 Apr; 34(4):582-6. PubMed ID: 23316006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-Phenylbutyric acid enhances the mineralization of osteogenesis imperfecta iPSC-derived osteoblasts.
    Takeyari S; Kubota T; Ohata Y; Fujiwara M; Kitaoka T; Taga Y; Mizuno K; Ozono K
    J Biol Chem; 2021; 296():100027. PubMed ID: 33154166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal type I collagen post-translational modification and crosslinking in a cyclophilin B KO mouse model of recessive osteogenesis imperfecta.
    Cabral WA; Perdivara I; Weis M; Terajima M; Blissett AR; Chang W; Perosky JE; Makareeva EN; Mertz EL; Leikin S; Tomer KB; Kozloff KM; Eyre DR; Yamauchi M; Marini JC
    PLoS Genet; 2014 Jun; 10(6):e1004465. PubMed ID: 24968150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical cell death and insufficient matrix organization in long-bone growth plates from Tric-b-knockout mice.
    Ichimura A; Miyazaki Y; Nagatomo H; Kawabe T; Nakajima N; Kim GE; Tomizawa M; Okamoto N; Komazaki S; Kakizawa S; Nishi M; Takeshima H
    Cell Death Dis; 2023 Dec; 14(12):848. PubMed ID: 38123563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term extracellular matrix metabolism by cultured human osteogenesis imperfecta osteoblasts.
    Fedarko NS; Sponseller PD; Shapiro JR
    J Bone Miner Res; 1996 Jun; 11(6):800-5. PubMed ID: 8725177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The swaying mouse as a model of osteogenesis imperfecta caused by WNT1 mutations.
    Joeng KS; Lee YC; Jiang MM; Bertin TK; Chen Y; Abraham AM; Ding H; Bi X; Ambrose CG; Lee BH
    Hum Mol Genet; 2014 Aug; 23(15):4035-42. PubMed ID: 24634143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crispr-Cas9 engineered osteogenesis imperfecta type V leads to severe skeletal deformities and perinatal lethality in mice.
    Rauch F; Geng Y; Lamplugh L; Hekmatnejad B; Gaumond MH; Penney J; Yamanaka Y; Moffatt P
    Bone; 2018 Feb; 107():131-142. PubMed ID: 29174564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type V OI primary osteoblasts display increased mineralization despite decreased COL1A1 expression.
    Reich A; Bae AS; Barnes AM; Cabral WA; Hinek A; Stimec J; Hill SC; Chitayat D; Marini JC
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E325-32. PubMed ID: 25387264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone biology: insights from osteogenesis imperfecta and related rare fragility syndromes.
    Besio R; Chow CW; Tonelli F; Marini JC; Forlino A
    FEBS J; 2019 Aug; 286(15):3033-3056. PubMed ID: 31220415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.